Philips announces new imaging and workflow enhancements for KODEX-EPD cardiac imaging and mapping system to treat heart rhyth...
August 26 2020 - 4:00AM
Philips announces new imaging and workflow enhancements for
KODEX-EPD cardiac imaging and mapping system to treat heart rhythm
disorders
August 26, 2020
- New release combines faster, higher resolution imaging for
Medtronic cryoablation procedures
- KODEX-EPD system now installed at 40 sites worldwide with over
1500 patients treated
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced new imaging and workflow enhancements for its novel
KODEX-EPD cardiac imaging and mapping system. The system is now
being used to treat patients with Atrial Fibrillation (AF), a
common heart rhythm disorder, at 40 sites worldwide with over 1500
patients treated. The latest release includes improvements in
imaging and mapping performance, as well as enhanced features to
support cryoablation procedures.
Unlike traditional methods to image the heart during AF
procedures such as CT and X-ray fluoroscopy, the KODEX-EPD system
uses a combination of sensors attached to the body and catheters
inside the heart to image the anatomy and properties of the heart,
using innovative dielectric sensing technology. As a result,
electrophysiologists can create detailed 3D views of the heart of a
patient in as little as three minutes and navigate to the target
location more easily and efficiently, with the required precision
and without using radiation.
“The new release of the KODEX-EPD system represents a
significant step forward in terms of image quality and workflow
efficiency for AF procedures, as we continue to work towards our
longer term goal of providing real-time therapy assessment,” said
Marlou Janssen, General Manager Philips EPD Solutions. “By
partnering with Medtronic and developing unique capabilities for
cryoablation, we can give more physicians access to this truly
innovative cardiac imaging and mapping system, and contribute to
delivering efficient workflows with Medtronic’s best-in-class
cryoablation therapy.”
Advances in the new release include faster, high-resolution
imaging, improvements in mapping functionality and point density,
as well as new visualization options such as ‘multi-chamber’ view
to help understand the relative positions of adjacent chambers and
‘glass view’, which provides physicians with an improved perception
of 3D catheter location and orientation within the heart. For
cryoablation procedures, the KODEX-EPD system offers enhanced
Occlusion assessment functionality with high accuracy and a
simplified workflow [1].
“Using the KODEX-EPD imaging system’s ability to provide high
resolution imaging, revealing specific pulmonary vein
morphologies, has allowed me to personalize my ablation approach in
Medtronic cryoballoon procedures,” said Marcin Kowalski MD,
Director of Electrophysiology at Staten Island University Hospital,
US. “Using the two innovative technologies together has significant
benefits for our patients.”
“Combining the short procedure times of cryoablation with the
real-time imaging capabilities of the KODEX-EPD system, we have
been able to further improve our efficient lab workflow” said
Professor Lukas Dekker, Electrophysiologist at Catharina Hospital
in Eindhoven, the Netherlands. “Moreover, fluoroless imaging with
the KODEX-EPD system may reduce the dependency on fluoroscopy and
pre-procedural CTs and thus help to reduce X-ray exposure to
patients and staff, which is important to us.”
The KODEX-EPD cardiac imaging and mapping system is commercially
available in the US, Europe, and China. It is part of Philips’
unique portfolio of systems, smart devices, software and services
in image-guided therapy, which combine to provide healthcare
providers with sophisticated, procedure-oriented solutions. More
information is available at www.philips.com/epd.
[1] While using KODEX-EPD occlusion functionality, physicians
should always refer to the applicable cryoballoon technical manual,
published literature, and exercise their discretion to guide
confirmation of pulmonary vein occlusion.
For further information, please contact:
Steve KlinkPhilips Group Press OfficeTel: +31 610 888 824Email:
steve.klink@philips.com
Fabienne van der FeerPhilips Image Guided TherapyTel: +31 622
698 001Email: fabienne.van.der.feer@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Surgeon discussing images to treat heart rhythm disorders
- Philips KODEX EPD monitor view in the lab
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024